Episode 1, A Precision Medicine Approach for Advanced Ovarian Cancer

In the first episode of A Deep Dive into HRD Testing in Ovarian Cancer, a three-part podcast series sponsored by AstraZeneca, we're speaking with Dr. Kathleen Moore about HRD testing in ovarian cancer and its clinical significance in helping aid precision medicine approaches. Dr. Kathleen Moore is a Professor of Gynecologic Oncology at the University of Oklahoma Health Sciences Center, Associate Director of Clinical Research and Director of the Oklahoma TSET Phase I Program at the Stephenson Cancer Center. A graduate of the University of Washington School of Medicine, WA, Dr. Moore completed her residency in gynecology at the University Health Center of Pittsburgh in Pittsburgh, PA and completed a fellowship in gynecologic oncology at the University of Oklahoma College of Medicine in Oklahoma City, OK. She is board certified in obstetrics and gynecology as well as gynecologic oncology and hospice and palliative care. For more information, visit: For patient resources, please visit TestForHRD.com . This podcast does not necessarily reflect the opinions of AstraZeneca and are the spokeperson's opinions and experience.

You can listen to Episode 1, A Precision Medicine Approach for Advanced Ovarian Cancer online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode 1, A Precision Medicine Approach for Advanced Ovarian Cancer is an episode from Oncology Times - OT Broadcasts from the iPad Archives by Oncology Times.

This episode is 16:40 long.

This episode was published on Feb 26, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Oncology Times - OT Broadcasts from the iPad Archives when more episodes are available from the podcast feed.